Board of Directors & Management

James S. Kuo, M.D., M.B.A. is the Chairman and Chief Executive Officer of Cordex Pharma, Inc., a publicly-traded company focused on clinically developing new pharmaceuticals for cardiovascular diseases. From 2003 to 2006, he served as founder, Chairman and Chief Executive Officer of BioMicro Systems, Inc., a profitable, venture-backed company commercializing a device for genetic analysis. Prior to that time, Dr. Kuo was co-founder, President and Chief Executive Officer of Discovery Laboratories, Inc., where he raised over $22 million in initial funding and took the company public. He has held senior licensing and business development positions at Pfizer, Inc., and Myriad Genetics, Inc. Dr. Kuo has also been the Managing Director at HealthCare Ventures, LLC, and Vice President at Paramount Capital Investments, LLC. Dr. Kuo is further a founder of Monarch Labs, LLP, a private company commercializing a medical device. Dr. Kuo simultaneously received his M.D. from the University of Pennsylvania School of Medicine and his M.B.A. from the Wharton School of Business.